GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharmarise Holdings Corp (TSE:2796) » Definitions » Return-on-Tangible-Asset

Pharmarise Holdings (TSE:2796) Return-on-Tangible-Asset : -1.78% (As of Feb. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Pharmarise Holdings Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Pharmarise Holdings's annualized Net Income for the quarter that ended in Feb. 2024 was 円-384 Mil. Pharmarise Holdings's average total tangible assets for the quarter that ended in Feb. 2024 was 円21,606 Mil. Therefore, Pharmarise Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Feb. 2024 was -1.78%.

The historical rank and industry rank for Pharmarise Holdings's Return-on-Tangible-Asset or its related term are showing as below:

TSE:2796' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -0.15   Med: 1.87   Max: 2.96
Current: 1.46

During the past 13 years, Pharmarise Holdings's highest Return-on-Tangible-Asset was 2.96%. The lowest was -0.15%. And the median was 1.87%.

TSE:2796's Return-on-Tangible-Asset is ranked worse than
50.52% of 675 companies
in the Healthcare Providers & Services industry
Industry Median: 1.53 vs TSE:2796: 1.46

Pharmarise Holdings Return-on-Tangible-Asset Historical Data

The historical data trend for Pharmarise Holdings's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmarise Holdings Return-on-Tangible-Asset Chart

Pharmarise Holdings Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 2.96 2.12 2.21 1.65

Pharmarise Holdings Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.76 2.51 2.42 2.98 -1.78

Competitive Comparison of Pharmarise Holdings's Return-on-Tangible-Asset

For the Pharmaceutical Retailers subindustry, Pharmarise Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmarise Holdings's Return-on-Tangible-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pharmarise Holdings's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Pharmarise Holdings's Return-on-Tangible-Asset falls into.



Pharmarise Holdings Return-on-Tangible-Asset Calculation

Pharmarise Holdings's annualized Return-on-Tangible-Asset for the fiscal year that ended in May. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: May. 2023 )  (A: May. 2022 )(A: May. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: May. 2023 )  (A: May. 2022 )(A: May. 2023 )
=333/( (20118+20172)/ 2 )
=333/20145
=1.65 %

Pharmarise Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Feb. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Feb. 2024 )  (Q: Nov. 2023 )(Q: Feb. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Feb. 2024 )  (Q: Nov. 2023 )(Q: Feb. 2024 )
=-384/( (19833+23378)/ 2 )
=-384/21605.5
=-1.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Feb. 2024) net income data.


Pharmarise Holdings  (TSE:2796) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Pharmarise Holdings Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Pharmarise Holdings's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmarise Holdings (TSE:2796) Business Description

Traded in Other Exchanges
N/A
Address
8 Floor, Sumitomo Nakano Sakue Building, 1-38-1 Chuo, Nakano-ku, Tokyo, JPN, 164-0011
Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.

Pharmarise Holdings (TSE:2796) Headlines

No Headlines